Saturday, December 06, 2008

ONE idea for Obama

From the ONE.org website: "President-elect Obama will have historic opportunities to bring hope and dignity to millions currently suffering from poverty and preventable diseases, such as malaria and HIV/AIDS.We can make a difference by showing our support for an inaugural affirmation of Obama's pledge to fight poverty and preventable diseases worldwide, and for an FY2010 Presidential budget request that puts the U.S. on track to meet Obama's historic commitments to the world's poorest people." Sign the online petition here:http://www.one.org/inauguration/


Presidents from JFK to Reagan have realized that poverty alleviation can be part of US policy and that it can be an effective way to help others and make America stronger. Of course, there is that dicey issue of spending the money effectively. Not spending it so we can pat ourselves on the back, but to catalyze real change. Always a challenge for government, which is multiplied in the area of foreign aid.
An example of where this could work better is government funding of medical research. This has lead to new vaccines and learnings about disease. But diseases of the "rest of the world" tend not to get the same priority.
While NIH says these diseases are a "high priority," US spending "...in global health has fallen short. NIH’s AIDS research funding was cut by $19 million from 2005 to 2006, and it has remained stagnant since then. Last year, just 0.3 percent of the NIH budget was devoted to malaria, and just 0.5 percent to TB.6 By failing to adequately fund NIH, the President’s 2008 budget further threatens our efforts to address global health issues." Global Health Initiative Report 2007 - Families USA
Congress and President Obama could step up- funding the NIH to focus more programs on TB, malaria, etc. could pay benefits on many levels. And it may be time to reprioritize NIH research programs. What are the expected public health returns on more research in, say, diabetes or obesity, compared to malaria or water borne disease?

This will also be an area where more government collaboration could help with dissemination. I have been very impressed by the work Rotary International, UNICEF, WHO and Gates Foundation in the Polio Eradication program. The Dept of Health & Human Services has supported this effort with significant resources. Looking for other multilateral efforts to improve public health, with existing technology such as the polio vaccine, could leverage results. The President's Malaria Initiative could be extended. Mosquito bed nets or clean water initiatives might benefit greatly from innovative partnerships and new types of US government support.

Wednesday, November 26, 2008

Starting A Venture Gapital Fund

Yesterday, I had a fun meeting with Sloan Entrepreneurs for International Development. My host, Jenny Kwan, asked me to come up with a topic to brainstorm with this group. So we spent an hour discussing what it would take to start a venture fund for enterprises in the BOP. What would be the same? what would be different?

We currently have a bifurcated market. On the one hand, traditional venture capital funds (VCs) look for deals that have the potential to return 30%+ on multi-million dollar investments. On the other hand, foundations and groups like Ashoka "invest" in social entrepreneurs without an expectation of even a return of principal. Kiva provides a return of principal, as do the "social businesses" advocated by Muhammad Yunus. So the question was whether a fund would work to fill this "gap" for BOP businesses that can generate a positive return, but would not attract VC due to a number of factors (smaller deal size, unfamiliar markets, lower ROI).

Here are a few ideas we kicked around as "venture gapitalists":

Fund size: I poked at the idea of "go big or go home" with a $100 million+ fund, but the general sense of the group was that this would need to be a relatively small fund ($15-25 million).

Deal flow: Fund size was driven by concern about deal flow in this sector. There was a good discussion about whether the fund will pick sectors (such as Acumen Fund) or instead invest in emerging businesses (such as those assisted by Endeavor). One idea that emerged was that it might be possible to carve up the General Partners' carried interest to those that helped with deal flow. We also discussed that others were doing due diligence on BOP firms for awards, etc, and it might be possible to take advantage of this starting point to help with deal flow. Several people also were concerned about investing in social entrepreneurs- they wanted to invest in profit maximizing entrepreneurs who would be pursuing liquidity for investors.

Team: Unanimous sense that you would need to build a team with local connections in the countries and sectors. Some concern that there were not many "serial social entrepreneurs" that could be recruited. Interesting to see the MBA perspective that few would be willing to start with fund if they felt it would require long term sacrifice on compensation. Most seemed to think that, properly structured, the fund could be competitive on compensation.

Cost structure: Many were concerned with the additional cost of a global network. While salaries are lower in other parts of the world, opening offices, reviewing deals, sitting on portfolio company boards all raised concerns.

General Partner fees: With cost concerns, some students felt a higher management fee would be required. 3-5% was proposed, but the "investors" were skeptical.

Syndication: The lack of other funds was a concern, as there are few others (yet) to share risk, due diligence, etc.

Investment strategy: some concern about investing in subsequent rounds (we noted that funds that are too small get squeezed as winners emerge in a portfolio if they can't invest in subsequent rounds). The sense of the group was that early rounds would be several hundred thousand (NOTE: this 1/10 conventional VC) and perhaps a bit over $1 million total capital. So the portfolio would be 15-30 companies.

Instruments: we didn't get into this in the main discussion, but after class we had an interesting chat about "additional terms" in, for instance, a convertible debt instrument. What if, for instance, the interest rate (or conversion discount) varied based on achieving social/environmental goals. The idea was that some investors might be willing to trade down on valuation if social returns were ACTUALLY being generated (as opposed to merely promissed) by the entrepreneur.

In short, we didn't figure it out. My sense is a number of people have been thinking about this, but have yet to come up with a business model that "works" enough to attract the human capital to run it, the financial capital to fund it, and an efficient deal flow screening mechanism. Just a matter of time, I think, before a few more "testable" models will emerge.

Monday, November 24, 2008

DiaBlog: Net Impact

I wasn't able to attend much of Net Impact this year, but several students from Colorado State reported back that the event at Wharton was better than ever. Below are some comments from Joseph Darnell and Mitesh Gala about this year's annual conference:

Q: What were the most interesting sessions you attended for BOPreneurs?
Mitesh: "Definitely the one on Socially Responsible Investing - There were three venture firms, including Innosight Ventures, headed by Clayton Christensen. They have invested in a laundry kiosk business in Bangalore."
Joseph: The biomimicry workshop was by far the most interesting panel I attended. I also thought the 'Hype vs. Reality: Impact and Potential of Social Enterprises in International Development' was particularly enlightening, and very relevant for any aspiring BOPreneur." (For Matt Austin's blog on this panel, click here)

Q: What were the key points you remember from these sessions?
Mitesh: "There doesn't have to be a trade-off between social business vs. traditional business. Both businesses are run on or evaluated on their bottom lines by the investors. However, investors use a more advanced evaluation tool to measure social impact and its effect on the bottom line, for instance, using a 'balanced scorecard' tool."
Joseph: "Some of the other business strategy applications from the world of nature were nearly mind-blowing. I liked insights like “optimize rather than maximize”, “use free energy”, and “ focus on shape, rather than material”. There was also talk of building within “ecological building codes” as opposed to the manmade versions we’ve invented. I really liked the business applications; Industry Biomes, Ecosystem Succession (as related to market entry) and Market Dietary Strategy (organism doesn’t define it’s food, it’s food defines the organism)."

Q: How are current global financial worries impacting MBAs' interest in sustainability and, more specifically, BOP work?
Joseph: "I think the interest in sustainability as a value add is only being heightened by the financial crisis. I think that it’s a way for MBAs to make themselves more attractive to employers. As for the BOP, it seems that interest in 'emerging markets' hasn’t waned."
Mitesh: "The conference had more panels on social businesses compared to last year and so it is hard to relate current financial worries with MBA's interest. There is still a lot more interest in CSR and Green technology, than in BOP work."